Polypharma celebrates 30th Anniversary

Jun 18, 2021 | Counterfeit Medicines, Development / Dossiers, Factory construction, Fairs / Events, Health, Innovation, Manufacturing Process, Medicines, Pharmaceutical Raw Materials / Laboratory Equipment, Registration Process

Single partner Polypharma offers a unique blend of services and skills that make it possible for it to act as a single partner accompanying local companies all the way from selection of target product through to actual receipt of raw materials for production. “Over...

EU approval of the first triple combination for asthma

Jul 22, 2020 | Medicines

The drug belonging to the DPI group administered in hard capsules consists of the ingredients indacaterol/glycopyrronium/mometasone (114 µg / 46 µg / 68 µg). This fixed tri-therapy is used in patients with insufficiently controlled asthma with a combination of a...

New oral formulation with Diclofenac

Jul 21, 2020 | Innovation, Medicines

In France, 50 mg of diclofenac epolamine granules for oral suspension in sachets have been granted marketing authorisation and are now available. The field of application extends over: short-term symptomatic treatment of acute seizures of extraarticular rheumatism...

Why a market analysis of your own market is so important

Jul 9, 2020 | Medicines

A market analysis is usually considered superfluous, here are a few reasons to change your mind: Markets and customers, and/or the top 10 diseases are changing: A market analysis helps to uncover the sometimes slow, sometimes fast changes in the market and not to lose...